Cyclerion Therapeutics Inc (NAS:CYCN)
$ 2.7 0.41 (17.98%) Market Cap: 6.75 Mil Enterprise Value: 1.05 Mil PE Ratio: 0 PB Ratio: 0.68 GF Score: 47/100

Cyclerion Therapeutics Inc at JPMorgan Healthcare Conference (Virtual) Transcript

Jan 14, 2021 / 08:40PM GMT
Release Date Price: $68.4 (-5.00%)
Bedir Shather

Hello, everyone. Good afternoon, and welcome to the 39th Annual JPMorgan Healthcare Conference. My name is Bedir Shather. I'm a Vice President in the Healthcare Investment Banking team here at JPMorgan. We're super excited to be having our next session with Cyclerion. And I'm going to hand it over to our next presenter, Peter Hecht. But before we do that, I just want to make sure that I've reminded everyone that we have a Q&A session at the end of this prepared remarks session, and you should be able to submit questions through the submit a question link, which is a blue bar on the page. And so with that, I'll hand it over to Peter.

Peter M. Hecht
Cyclerion Therapeutics, Inc. - CEO & Director

Thank you, Bedir. And thank you to not only yourself, but to your whole team. It's been a great week for us. It's been a really terrific opportunity to participate in the conference and to share our excitement for our mission to develop treatments that restore cognitive function. And if you don't mind lingering briefly on Slide 2, you all can control the

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot